Turn off the IDO: will clinical trials be successful?
نویسندگان
چکیده
Indoleamine 2,3-dioxygenase (IDO) is overexpressed in many human cancers and is believed to play a role in tumor immune evasion, but a requirement for IDO in tumor progression has not been formally shown. The study by Smith and colleagues in this issue of Cancer Discovery provides genetic evidence for the importance of IDO in tumorigenesis, which supports the use of IDO inhibitors in clinical trials in humans.
منابع مشابه
IN THE SPOTLIGHT Turn Off the IDO: Will Clinical Trials Be Successful?
Indoleamine 2,3-dioxygenase (IDO) is an intracellular heme-containing enzyme that is highly expressed in myeloid cells (e.g., macrophages, dendritic cells) and catalyzes the initial step in tryptophan degradation by the kynurenine pathway. Tryptophan starvation by IDO activation inhibits T-cell function by several mechanisms. First, tryptophan depletion can directly lead to T-cell growth arrest...
متن کاملO12: Off the Couch and Out the Door: Improving Treatment Through a Refined Understanding of Psychotherapeutic Change
State-of-the-art psychotherapy for anxiety disorders represents some of the most efficacious treatments in the mental health literature. Nevertheless, these treatments are not panacea. Too many patients drop out of treatment, response rates leave room for improvement, and residual symptomatology is common. The quest to improve therapy for patients suffering from mental disorders necessitates on...
متن کاملThe Indoleamine-2,3-Dioxygenase (IDO) Inhibitor 1-Methyl-D-tryptophan Upregulates IDO1 in Human Cancer Cells
1-methyl-D-tryptophan (1-D-MT) is currently being used in clinical trials in patients with relapsed or refractory solid tumors with the aim of inhibiting indoleamine-2,3-dioxygenase (IDO)-mediated tumor immune escape. IDO is expressed in tumors and tumor-draining lymph nodes and degrades tryptophan (trp) to create an immunsuppressive micromilieu both by depleting trp and by accumulating immunos...
متن کاملEffect of Procedures AugmentedFeedback Presentation (after Successful and Unsuccessful Trials), on Learning and Error Detection Capability, in Force-Produce Task
The aim of this study was examining the effect of knowledge of results presentation (after successful and unsuccessful trials), on learning and error detection capability in force-produce task. Sixty under graduated students (range age 21.6±4), participated in this study and in order to KR presentation, divided in three groups. One of the groups received KR after successful trials, the other gr...
متن کاملدرماتولوژی مبتنی بر شواهد: گزارش درست مقایسه‌ی پیامدها در کارآزمایی‌های بالینی
According to evidence-based medicine, randomized controlled clinical trials are a group of research designs which provides the highest level of clinical evidence, particularly regarding therapeutic or preventive interventions. Considering the dramatic increase in the number of published clinical trials in medical journals, the readership need to have knowledge about the problems that may occur ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Cancer discovery
دوره 2 8 شماره
صفحات -
تاریخ انتشار 2012